Ryan H. Flax
67 IP cases indexed. Covers patent matters.
Cases Presided Over
67 cases indexed | Page 2 of 3
National Beef Packing Company, LLC v.Institute for Environmental Health, Inc.
National Beef Packing and Institute for Environmental Health settled their inter partes review of U.S. Patent 7,534,584. The Board terminated the proceeding without a merits decision, granting confidentiality for the settlement.
Jeisys Medical Inc. et al. v.Serendia, LLC
EndyMed Medical and Serendia settled their inter partes review disputes over U.S. Patent 9,775,774, leading the PTAB to terminate the proceedings and keep the settlement confidential.
Jeisys Medical Inc. et al. v.Serendia, LLC
Serendia and Jeisys Medical settled their IPR dispute over U.S. Patent 9,320,536, leading the PTAB to terminate the proceeding.
Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.
Dyson Technology and Omachron reached a settlement, leading the PTAB to terminate IPR2024-00690 concerning patent 10,117,550 B1. The settlement agreement is kept confidential under 35 U.S.C. § 317(b).
EndyMed Medical Ltd. et al. v.Serendia, LLC
EndyMed Medical and Serendia settled their inter partes review of U.S. Patent 9,480,836, leading the PTAB to terminate the proceeding. The settlement agreement is treated as confidential business information.
NeoGenomics Laboratories, Inc. v.Natera, Inc.
NeoGenomics filed an IPR challenging Natera's prenatal‑testing patent. The parties settled before the Board could institute the trial, and the Board granted a joint motion to terminate the proceeding.
Anker Innovations Ltd. v.Powermat Technologies Ltd.
Anker Innovations and Powermat Technologies settled their IPR dispute over wireless charging patents, leading the PTAB to terminate the proceeding. No merits were decided.
National Beef Packing Company, LLC v.Institute for Environmental Health, Inc.
National Beef and Institute for Environmental Health settled four inter partes reviews covering patents 7,534,584; 8,822,143; 9,637,771; and 9,845,486. The Board terminated the proceedings based on a written settlement agreement and granted confidentiality for the agreement.
Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.
Dyson and Omachron settled their inter partes review disputes before the PTAB instituted the trial, resulting in termination of the proceedings and confidentiality of the settlement agreement.
Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.
Dyson and Omachron settled their inter partes review dispute over U.S. Patent 11,910,983 B2. The Board granted a joint motion to terminate the proceeding and treated the settlement agreement as confidential.
C.R. Bard, Inc. et al. v.Medline Industries, LP
C.R. Bard's IPR challenge to Medline Industries' patent was terminated after the parties reached a settlement, with the Board granting a joint motion to dismiss before instituting the trial.
MIM Software Inc. et al. v.EXINI Diagnostics AB, Inc. et al.
MIM Software and EXINI Diagnostics settled their inter partes review, leading the PTAB to terminate the proceeding and keep the settlement agreement confidential.
Henri Daussi, LLC v.ECNA, LLC et al.
The PTAB denied Henri Daussi, LLC's motion to withdraw its IPR petition against ECNA, LLC's patent 9,398,791, while allowing the parties to file a joint motion to terminate the proceeding after settling.
GetTattle, Inc. v.AfterWords, Inc.
GetTattle, Inc. successfully petitioned to institute IPR against AfterWords, Inc.'s patent (10430811) based on anticipation grounds (§ 102). The Board found sufficient support in prior art references Douglas and Ganesh for all challenged claims, leading to the institution of the case.
CSPC Megalith Biopharmaceutical Co., Ltd. et al. v.Shanghai Miracogen Inc. et al.
CSPC Megalith Biopharmaceutical Co., Ltd. successfully argued obviousness over Wei, Liu, and Leanna in an IPR proceeding against Shanghai Miracogen Inc. The Board found a reasonable likelihood of success on multiple claims, leading to the institution of the case for trial.
MIM Software Inc. et al. v.EXINI Diagnostics AB, Inc. et al.
MIM Software Inc. successfully petitioned to institute IPR against EXINI Diagnostics AB, Inc.'s patent (11941817) on grounds of anticipation and obviousness. The Board found reasonable likelihood that the claims are unpatentable based on prior art references like Renisch and Zhao.
Dexcom, Inc. v.Abbott Diabetes Care Inc.
Dexcom and Abbott Diabetes Care settled their IPR dispute over U.S. Patent 11,298,056 covering continuous glucose monitoring technology. The parties filed a joint motion to terminate, and the Board granted termination without a final written decision.
Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.
Dyson and Omachron settled their dispute over U.S. Patent 8,607,407 B2. The parties jointly moved to terminate the IPR, and the Board granted the motion, ending the proceeding.
Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.
Dyson and Omachron settled their dispute over U.S. Patent 10,327,607 B2, leading the PTAB to terminate the inter partes review by joint motion.
Cimbra SRL et al. v.3U Vision SRL
CIMBRIA SRL and 3U Vision settled their dispute over U.S. Patent 11,666,947, leading to a joint motion that terminated the post‑grant review. The Board granted the termination and ordered the settlement agreement to remain confidential.
First Quality Enterprises, LLC et al. v.Essity Hygiene and Health AB
The PTAB granted institution for the IPR challenge against Essity Hygiene and Health AB's absorbent article patent (9308138). The Board found a reasonable likelihood of prevailing on multiple claims based on obviousness over prior art, including Nakazawa.
Valneva Austria GMBH v.Takeda Vaccines, Inc.
Valneva Austria GMBH successfully convinced the PTAB to institute IPR proceedings against Takeda Vaccines regarding a vaccine patent. The Board found a reasonable likelihood that several claims are unpatentable over combinations of prior art, specifically citing evidence related to fetal protection and antibody transfer.
Straumann USA, LLC et al. v.Smart Denture Conversions, LLC.
Straumann USA, LLC successfully petitioned against Smart Denture Conversions, LLC's patent, leading to institution of IPR proceedings. The Board found a reasonable likelihood that claims are unpatentable under both anticipation (102) and obviousness (103).
Front Line Medical Technologies Inc. v.Prytime Medical Devices, Inc.
The PTAB institution decision found that the petitioner successfully demonstrated a likelihood of prevailing on its obviousness challenges against all ten claims. The Board adopted broad claim constructions for 'proximal hub' and 'flow valve,' finding they could be separate or sub-elements, which supported the grounds of obviousness over various prior art combinations.
Straumann USA, LLC et al. v.Smart Denture Conversions, LLC.
Straumann USA successfully petitioned for institution in a Post-Grant Review challenging Smart Denture Conversions' dental implant patent (12156781). The Board found likelihood of unpatentability based on indefiniteness and lack of written description/enablement. This sets a precedent regarding the sufficiency of disclosure in complex medical device claims.
Ilooda Co., Ltd. et al. v.Serendia, LLC
EndyMed Medical and Serendia, LLC entered a settlement that resolved all disputes over three patents, leading the PTAB to terminate the associated IPRs. The settlement agreement was deemed confidential business information.
Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.
Dr. Reddy’s Laboratories and Eye Therapies entered a settlement that led to the joint termination of two inter partes review proceedings covering patents 11,833,245 and 11,596,600. The Board granted the termination and kept the settlement agreement confidential.
National Beef Packing Company, LLC v.Institute for Environmental Health, Inc.
National Beef and Institute for Environmental Health settled four inter partes review proceedings, resulting in the termination of all petitions without a merits decision. The Board granted the joint motion to terminate and kept the settlement agreement confidential.
National Beef Packing Company, LLC v.Institute for Environmental Health, Inc.
National Beef Packing Company and Institute for Environmental Health settled their inter partes review, leading the PTAB to terminate the proceeding and dismiss the petition.
Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.
Dr. Reddy’s and Eye Therapies settled their IPR dispute, resulting in a joint motion that terminated the proceedings. The Board granted the termination and kept the settlement confidential.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.